Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR
- Author
- HICKS, David G1 ; SHORT, Sarah M1 ; TUBBS, Raymond R1 ; CASEY, Graham4 ; WEIL, Robert J3 5 ; PRESCOTT, Nichole L1 ; TARR, Shannon M1 ; COLEMAN, Kara A1 ; YODER, Brian J1 ; CROWE, Joseph P2 ; CHOUEIRI, Toni K3 ; DAWSON, Andrea E1 ; BUDD, G. Thomas3
[1] Clinical and Anatomic Pathology, Cleveland Clinic Foundation, Cleveland, OH 44195, United States
[2] Breast Center, Cleveland Clinic Foundation, Cleveland, OH 44195, United States
[3] Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, OH 44195, United States
[4] Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, United States
[5] Brain Tumor Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, United States - Source
The American journal of surgical pathology. 2006, Vol 30, Num 9, pp 1097-1104, 8 p ; ref : 50 ref
- CODEN
- AJSPDX
- ISSN
- 0147-5185
- Scientific domain
- General medicine general surgery
- Publisher
- Lippincott Williams & Wilkins, Hagerstown, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- CK5/6 CNS recurrence EGFR HER2 basal phenotype brain metastasis breast adenocarcinoma
- Keyword (fr)
- Adénocarcinome sein Anatomopathologie Cancer cerveau Cytokératine Gène erbB2 Gène onc cellulaire Oestrogène Phénotype Protooncogène Récepteur facteur croissance épiderme Récepteur hormonal Récepteur oestrogène Récidive Surexpression génique Cancer sein Métastase cérébrale Récepteur HER2 Encéphale pathologie Glande mammaire pathologie Hormone ovarienne Hormone stéroïde sexuelle Système nerveux central pathologie Système nerveux pathologie Tumeur maligne
- Keyword (en)
- Breast adenocarcinoma Anatomic pathology Brain cancer Cytokeratin erbB2 Gene C-Onc gene Estrogen Phenotype Protooncogene Epidermal growth factor receptor Hormonal receptor Estrogen receptor Relapse Gene overexpression Breast cancer Cerebral metastasis Human Epidermal growth factor Receptor 2 Cerebral disorder Mammary gland diseases Ovarian hormone Sex steroid hormone Central nervous system disease Nervous system diseases Malignant tumor
- Keyword (es)
- Adenocarcinoma pecho Anatomía patológica Cáncer cerebro Citoqueratina Gen erbB2 Gen onc celular Estrógeno Fenotipo Protooncogen Receptor factor crecimiento epidermi Receptor hormonal Receptor estrógeno Recaida Sobreexpressión genética Cáncer pecho Metástasis cerebral Encéfalo patología Glándula mamaria patología Hormona ovárica Hormona esteroide sexual Sistema nervosio central patología Sistema nervioso patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20E Mammary gland diseases / 002B20E02 Tumors
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B24 Investigative techniques, diagnostic techniques (general aspects) / 002B24O Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques
- Discipline
- Gynecology. Andrology. Obstetrics Scanning and diagnostic techniques
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 18102867
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1097/01.pas.0000213306.05811.b9 
https://dx.doi.org/10.1097/01.pas.0000213306.05811.b9
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.pas.0000213306.05811.b9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5\/6, and overexpress HER2 or EGFR\";s:9:\"\u0000*\u0000jtitle\";s:42:\"The American journal of surgical pathology\";s:9:\"\u0000*\u0000stitle\";s:19:\"Am. j. surg. pathol\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1097\";s:8:\"\u0000*\u0000epage\";s:4:\"1104\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0147-5185\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"HICKS\";s:10:\"\u0000*\u0000aufirst\";s:7:\"David G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:14:\"SHORT, Sarah M\";i:1;s:16:\"TUBBS, Raymond R\";i:2;s:13:\"CASEY, Graham\";i:3;s:14:\"WEIL, Robert J\";i:4;s:19:\"PRESCOTT, Nichole L\";i:5;s:15:\"TARR, Shannon M\";i:6;s:15:\"COLEMAN, Kara A\";i:7;s:14:\"YODER, Brian J\";i:8;s:15:\"CROWE, Joseph P\";i:9;s:16:\"CHOUEIRI, Toni K\";i:10;s:16:\"DAWSON, Andrea E\";i:11;s:15:\"BUDD, G. Thomas\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJSPDX\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5\/6, and overexpress HER2 or EGFR\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.pas.0000213306.05811.b9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5\/6, and overexpress HER2 or EGFR\";s:9:\"\u0000*\u0000jtitle\";s:42:\"The American journal of surgical pathology\";s:9:\"\u0000*\u0000stitle\";s:19:\"Am. j. surg. pathol\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1097\";s:8:\"\u0000*\u0000epage\";s:4:\"1104\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0147-5185\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"HICKS\";s:10:\"\u0000*\u0000aufirst\";s:7:\"David G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:14:\"SHORT, Sarah M\";i:1;s:16:\"TUBBS, Raymond R\";i:2;s:13:\"CASEY, Graham\";i:3;s:14:\"WEIL, Robert J\";i:4;s:19:\"PRESCOTT, Nichole L\";i:5;s:15:\"TARR, Shannon M\";i:6;s:15:\"COLEMAN, Kara A\";i:7;s:14:\"YODER, Brian J\";i:8;s:15:\"CROWE, Joseph P\";i:9;s:16:\"CHOUEIRI, Toni K\";i:10;s:16:\"DAWSON, Andrea E\";i:11;s:15:\"BUDD, G. Thomas\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJSPDX\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5\/6, and overexpress HER2 or EGFR\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.pas.0000213306.05811.b9\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.pas.0000213306.05811.b9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5\/6, and overexpress HER2 or EGFR\";s:9:\"\u0000*\u0000jtitle\";s:42:\"The American journal of surgical pathology\";s:9:\"\u0000*\u0000stitle\";s:19:\"Am. j. surg. pathol\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1097\";s:8:\"\u0000*\u0000epage\";s:4:\"1104\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0147-5185\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"HICKS\";s:10:\"\u0000*\u0000aufirst\";s:7:\"David G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:14:\"SHORT, Sarah M\";i:1;s:16:\"TUBBS, Raymond R\";i:2;s:13:\"CASEY, Graham\";i:3;s:14:\"WEIL, Robert J\";i:4;s:19:\"PRESCOTT, Nichole L\";i:5;s:15:\"TARR, Shannon M\";i:6;s:15:\"COLEMAN, Kara A\";i:7;s:14:\"YODER, Brian J\";i:8;s:15:\"CROWE, Joseph P\";i:9;s:16:\"CHOUEIRI, Toni K\";i:10;s:16:\"DAWSON, Andrea E\";i:11;s:15:\"BUDD, G. Thomas\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJSPDX\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5\/6, and overexpress HER2 or EGFR\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.pas.0000213306.05811.b9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5\/6, and overexpress HER2 or EGFR\";s:9:\"\u0000*\u0000jtitle\";s:42:\"The American journal of surgical pathology\";s:9:\"\u0000*\u0000stitle\";s:19:\"Am. j. surg. pathol\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1097\";s:8:\"\u0000*\u0000epage\";s:4:\"1104\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0147-5185\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"HICKS\";s:10:\"\u0000*\u0000aufirst\";s:7:\"David G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:14:\"SHORT, Sarah M\";i:1;s:16:\"TUBBS, Raymond R\";i:2;s:13:\"CASEY, Graham\";i:3;s:14:\"WEIL, Robert J\";i:4;s:19:\"PRESCOTT, Nichole L\";i:5;s:15:\"TARR, Shannon M\";i:6;s:15:\"COLEMAN, Kara A\";i:7;s:14:\"YODER, Brian J\";i:8;s:15:\"CROWE, Joseph P\";i:9;s:16:\"CHOUEIRI, Toni K\";i:10;s:16:\"DAWSON, Andrea E\";i:11;s:15:\"BUDD, G. Thomas\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJSPDX\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5\/6, and overexpress HER2 or EGFR\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.pas.0000213306.05811.b9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5\/6, and overexpress HER2 or EGFR\";s:9:\"\u0000*\u0000jtitle\";s:42:\"The American journal of surgical pathology\";s:9:\"\u0000*\u0000stitle\";s:19:\"Am. j. surg. pathol\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1097\";s:8:\"\u0000*\u0000epage\";s:4:\"1104\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0147-5185\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"HICKS\";s:10:\"\u0000*\u0000aufirst\";s:7:\"David G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:14:\"SHORT, Sarah M\";i:1;s:16:\"TUBBS, Raymond R\";i:2;s:13:\"CASEY, Graham\";i:3;s:14:\"WEIL, Robert J\";i:4;s:19:\"PRESCOTT, Nichole L\";i:5;s:15:\"TARR, Shannon M\";i:6;s:15:\"COLEMAN, Kara A\";i:7;s:14:\"YODER, Brian J\";i:8;s:15:\"CROWE, Joseph P\";i:9;s:16:\"CHOUEIRI, Toni K\";i:10;s:16:\"DAWSON, Andrea E\";i:11;s:15:\"BUDD, G. Thomas\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJSPDX\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5\/6, and overexpress HER2 or EGFR\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
